Therapeutic management of severe spinal cord decompression sickness in a hyperbaric center. | Canada Hyperbarics Skip to main content
Retrospective Study Frontiers in medicine 2023

Therapeutic management of severe spinal cord decompression sickness in a hyperbaric center.

Simonnet B, Roffi R, Lehot H, Morin J, Druelle A, Daubresse L, et al. — Frontiers in medicine, 2023

View Original on PubMed PMID 37746073
Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers conducted a retrospective study at a single hyperbaric center to evaluate the therapeutic management of severe spinal cord decompression sickness (scDCS) and the influence of different hyperbaric recompression tables.

What They Found

The study included 102 divers (average age 52 years). They found that high initial clinical severity, deterioration within 24 hours, and recompression using 4 atm tables were associated with incomplete neurological recovery, whereas 2.8 atm tables resulted in significantly fewer sequelae.

Canadian Relevance

This study was not conducted in Canada and does not have a direct Canadian connection.

Study Limitations

A limitation of this study is its retrospective design and reliance on data from a single hyperbaric center.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Retrospective Study
Category Neurological
Source Pubmed
PubMed ID 37746073
Year Published 2023
Journal Frontiers in medicine

Cite This Study

Share

Related Research

PLoS ONE | 2013 RCT

Hyperbaric oxygen induces late neuroplasticity in post stroke patients--randomized, prospective trial.

Efrati S, Fishlev G, Bechor Y, et al.
J Neurotrauma | 2018 Systematic Review

Hyperbaric oxygen therapy in the treatment of acute severe traumatic brain injury: a systematic review

Daly S, Thorpe M, Rockswold S, et al.
J Neurotrauma | 2012 Pilot Study

A phase I study of low-pressure hyperbaric oxygen therapy for blast-induced post-concussion syndrome and PTSD

Harch PG, Andrews SR, Fogarty EF, et al.
Scientific Reports | 2022 RCT

Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial.

Hadanny A, Zilberman-Itskovich S, Catalogna M, et al.
PLoS ONE | 2013 RCT

Hyperbaric oxygen therapy can improve post concussion syndrome years after mild traumatic brain injury — randomized prospective trial

Boussi-Gross R, Golan H, Fishlev G, et al.
See all Neurological research
View on PubMed Back to Research Library
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 2, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology